autologous anti-PD-1 antibody-activated tumor-infiltrating lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-011489
A preparation of autologous tumor infiltrating lymphocytes (TILs) activated by an anti-programmed cell death protein 1 (PD1) antibody, with potential immunomodulating activity. The autologous TILs are isolated from an autologous tumor sample and ex-vivo activated in the presence of anti-PD-1 antibody. Upon infusion of the autologous anti-PD1 antibody-activated TILs back into the patient, the cells specifically target and kill the patient's tumor cells.
| Identifier | MLC-T-ONC-011489 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous anti-PD-1 antibody-activated TILs; anti-PD1 antibody-activated autologous TILs |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011489",
"term": "autologous anti-PD-1 antibody-activated tumor-infiltrating lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous tumor infiltrating lymphocytes (TILs) activated by an anti-programmed cell death protein 1 (PD1) antibody, with potential immunomodulating activity. The autologous TILs are isolated from an autologous tumor sample and ex-vivo activated in the presence of anti-PD-1 antibody. Upon infusion of the autologous anti-PD1 antibody-activated TILs back into the patient, the cells specifically target and kill the patient's tumor cells.",
"synonyms": [
"autologous anti-PD-1 antibody-activated TILs",
"anti-PD1 antibody-activated autologous TILs"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-anti-pd-1-antibody-activated-tumor-infiltrating-lymphocytes/"
}
Record 2,821 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.